In clinical samples, CLEC4G mRNA expression was seen to be higher in cancer tissues than in paracancerous tissues of HCC patients (p < 0.01, Figure 4a), validating the results of the analysis of the appealing biological information. The gene discussed is CLEC4G; the disease is cancer.